Yale Cancer Center — New Haven, Connecticut

Public research footprint of Yale Cancer Center, compiled from the ClinicalTrials.gov public registry.

436

Registered studies

180

Active

116

Recruiting now

175

Completed

Stopped or withdrawn

Most-studied conditions

Breast Cancer · Advanced Solid Tumor · Pancreatic Ductal Adenocarcinoma · Glioblastoma Multiforme (GBM)

Recently updated registry entries

NCT05232916 — Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 +… (Recruiting)
NCT07222267 — An Investigational Study of BG-75202 Alone and in Combination With Other Therapeutic… (Recruiting)
NCT07326566 — Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Yale Cancer Center?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.